Your browser doesn't support javascript.
loading
Sustainable return to work among breast cancer survivors.
Ruiz de Azua, Garazi; Kousignian, Isabelle; Vaz-Luis, Ines; Di Meglio, Antonio; Caumette, Elsa; Havas, Julie; Martin, Elise; Martin, Anne-Laure; Querel, Ophelie; Vanlemmens, Laurence; Pistilli, Barbara; Coutant, Charles; Cottu, Paul Henri; Merimeche, Asma Dhaini; Lerebours, Florence; Tredan, Olivier; Jouannaud, Christelle; Levy, Christelle; Dumas, Agnes; Menvielle, Gwenn.
Afiliación
  • Ruiz de Azua G; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, IPLESP, Équipe de Recherche en Épidémiologie Sociale, Paris, France.
  • Kousignian I; Université Paris Cité, Unité de Recherche «Biostatistique, Traitement et Modélisation des données bio-logiques¼ BioSTM, UR 7537, Paris, France.
  • Vaz-Luis I; Medical Oncology Department, Gustave Roussy, Villejuif, France.
  • Di Meglio A; INSERM Unit 981-Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy, Villejuif, France.
  • Caumette E; INSERM Unit 981-Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy, Villejuif, France.
  • Havas J; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, IPLESP, Équipe de Recherche en Épidémiologie Sociale, Paris, France.
  • Martin E; Department of Maieutics, Université de Montpellier, Montpellier, France.
  • Martin AL; INSERM Unit 981-Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy, Villejuif, France.
  • Querel O; INSERM Unit 981-Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy, Villejuif, France.
  • Vanlemmens L; UCBG, UNICANCER, Paris, France.
  • Pistilli B; UCBG, UNICANCER, Paris, France.
  • Coutant C; Centre Oscar Lambret, Lille, France.
  • Cottu PH; Breast Cancer Group, Institut Gustave-Roussy, Villejuif, France.
  • Merimeche AD; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.
  • Lerebours F; Department of Medical Oncology, Institut Curie, Paris, France.
  • Tredan O; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France.
  • Jouannaud C; Department of Medical Oncology, Institut Curie, Saint-Cloud, France.
  • Levy C; Centre Léon Berard, Lyon, France.
  • Dumas A; Institut Jean Godinot Reims, Reims, France.
  • Menvielle G; Centre François Baclesse, Caen, France.
Cancer Med ; 12(18): 19091-19101, 2023 Sep.
Article en En | MEDLINE | ID: mdl-37602836
PURPOSE: This study assessed sustainable return to work (SRTW) of breast cancer survivors (BCS). METHODS: We used data from the prospective French cohort, CANTO. We included 1811 stage I-III BCS who were <57 years old and employed at the moment of diagnosis and working 2 years after diagnosis. Using logistic regression, we investigated the role of clinical, health and socio-economic factors, and the work environment on SRTW 3 years after diagnosis. We compared having any sick leave with having worked continuously and being unemployed to having worked continuously between 2 and 3 years after diagnosis. RESULTS: Overall, 77% (n = 1395) worked continuously after return to work (RTW). Out of the other 416 BCS, 66% had any sick leave period, 33% had been unemployed, 4% had an early retirement, 2% a disability and 1% another status (multiple situations possible). Being on sick leave was associated with age > 50 (OR = 0.59; 95%CI = 0.43-0.82), stage III (2.56; 1.70-3.85), tumour subtype HR+/HER2+ (0.61; 0.39-0.95), severe fatigue (1.45; 1.06-1.98), workplace accommodations (1.63; 1.14-2.33) and life priorities (0.71; 0.53-0.95). Unemployment was associated with age > 50 (0.45; 0.29-0.72), working in the public sector (0.31; 0.19-0.51), for a small company (3.00; 1.74-5.20) and having a fixed-term contract (7.50; 4.74-11.86). CONCLUSIONS: A high number of BCS have periods of sick leave or unemployment after RTW. The determinants differ between sick leave and unemployment. IMPLICATIONS FOR CANCER SURVIVORS: BCS need to be supported even after RTW, which should be regarded as a process.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Aspecto: Patient_preference Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Aspecto: Patient_preference Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos